Key result
Pulmonary ACE expression is present in normal fetal lungs from 12 weeks gestation and remains active postnatally, but is largely absent or weakly expressed in bronchopulmonary dysplasia lungs.
Observational
ACE expression is active during normal human lung development but downregulated in bronchopulmonary dysplasia, suggesting a potential role in lung development and BPD pathobiology.
Answers are grounded in this paper and cite their sources.
May inform BPD pathobiology; hypothesis-generating for ACE-targeted interventions, requiring validation before any clinical consideration.
INTRODUCTION: The mammalian lung possesses the highest level of angiotensin converting enzyme (ACE) amongst all the organs. ACE is known to generate angiotensin (AT)-II from AT-I and to regulate serum bradykinin level, thereby controlling blood pressure. Recent data, however, indicate a role for ACE derived AT-II in angiogenesis, pulmonary hypertension, and neonatal lung disease. The ontogeny of ACE in humans has not been investigated. We studied pulmonary ACE expression during human lung development and in human bronchopulmonary dysplasia (BPD). MATERIAL AND METHODS: Human fetal autopsy lung tissue representing all three trimesters (12, 13, 16, 18, 24, 34, 39, and 40 weeks of gestational age (WGA)), as well as from 1 to 10 years of age with no significant lung pathology were used. In addition lung sections of patients with BPD (n = 5) were selected. The slides were immunostained using an anti-ACE monoclonal antibody. The temporal and spatial pattern of ACE expression was contrasted to that of the pan-endothelial marker CD31. Staining intensity was graded. RESULTS: Mildly diffuse and strong microvascular endothelial immunreactivity for ACE was seen in the human fetus as early as 12 WGA. ACE expression peaked at mid gestation and remained high throughout gestation and postnatally. In BPD lungs ACE endothelial staining was largely absent, and when focal staining was observed the intensity was weak. CONCLUSION: We established that ACE expression is present in the human fetal lung as early as 12 WGA, remains active pre- and postnatally, and ACE expression was downregulated in BPD lungs. We speculate that ACE may be involved in the process of lung development.
No takes yet. Share an insight, caveat, or question.
Castro et al. (2013) conducted an observational in Bronchopulmonary dysplasia (BPD). Bronchopulmonary dysplasia (BPD) vs. Normal lung tissue was evaluated on ACE expression pattern and intensity. Pulmonary ACE expression is present in normal fetal lungs from 12 weeks gestation and remains active postnatally, but is largely absent or weakly expressed in bronchopulmonary dysplasia lungs.
Synapse has enriched 10 related papers. Consider them for comparative context: